Diabetic retinopathy, which is a complication of diabetes and results in vision loss and blindness, can be effectively treated via injectable steroids. This finding was revealed in a new study that was led by researcher Dr Neil M. Bressler of Johns Hopkins University School of Medicine.

Proliferative diabetic retinopathy happens when new blood vessels are formed on the optic disc or another component of the retina. Though laser treatments can considerably reduce the risk of vision loss and control of blood glucose can prevent the development of retinopathy, yet there is a need for identification of other treatments.

From Timesofindia.indiatimes.com:

“Use of this intravitreal [injected into the eye] corticosteroid preparation to reduce the likelihood of progression of retinopathy is not warranted at this time because of the increased risk of glaucoma and cataract associated with intravitreal steroid use,” the authors write.

“Any treatment to be used routinely to prevent proliferative diabetic retinopathy likely needs to be relatively safe because the condition already can be treated successfully and safely with panretinal photocoagulation.

“Nevertheless, further investigation with regard to the role of pharmacotherapy for reduction of the incidence of progression of retinopathy appears to be warranted,” they added.

This study appeared in journal Archives of Ophthalmology, one of the JAMA/Archives journals.

Bookmark It

Hide Sites

Tags: blindness, corticosteroid, Proliferative diabetic retinopathy, steroid use

Posted in Steroid Cycles, Steroids and Anabolic Steroids, buy steroids, steroid nation